Abdominal Obesity Metabolic SyndromeSymptoms, Doctors, Treatments, Advances & More
Abdominal Obesity Metabolic Syndrome Overview
Learn About Abdominal Obesity Metabolic Syndrome
Texas Health Family Care
Emily Mccullar is a primary care provider, practicing in Family Medicine in Rockwall, Texas. Dr. Mccullar is rated as an Advanced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and Hypothyroidism. Dr. Mccullar is currently accepting new patients.
LVPG Family Medicine-Hometown
Recaredo Berbano is an Endocrinologist practicing medicine in Tamaqua, Pennsylvania. Dr. Berbano is rated as a Distinguished provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Abdominal Obesity Metabolic Syndrome, Type B Insulin Resistance Syndrome, Mitochondrial Complex V Deficiency, and Cytochrome C Oxidase Deficiency. Dr. Berbano is currently accepting new patients.
Franciscan Medical Clinic - Bonney Lake
Kamyar Vaziri is a primary care provider, practicing in Internal Medicine in Bonney Lake, Washington. Dr. Vaziri is rated as an Experienced provider by MediFind in the treatment of Abdominal Obesity Metabolic Syndrome. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Hypertension, Familial Hypertension, Vitrectomy, and Trabeculectomy. Dr. Vaziri is board certified in American Board Of Internal Medicine. Dr. Vaziri is currently accepting new patients.
Background: The pituitary gland produces hormones. A tumor in this gland can cause it to produce too much of the hormone cortisol. Too much cortisol in the body causes Cushing disease. This disease causes many problems. Some of these problems might persist after the disease is cured.
Summary: The overall purpose of this study is to learn more about the metabolic effects of angiotensin-(1-7) in the insulin resistant state associated with obesity. Pharmacologic approaches to increase angiotensin-(1-7) levels or its actions are currently in development for treatment of metabolic-related diseases such as obesity and type II diabetes, based on findings from animal studies. It is unclear if ...

